RecallDepth
Class III Terminated

Evrysdi (risdiplam) for oral solution, 60 mg/80mL (0.75mg/mL), 80 mL total volume after constitution, Rx only, Distributed by: Genentech, Inc. NDC:50242-175-05

Company
Genentech, Inc.
Recall Initiated
April 20, 2021
Posted
May 5, 2021
Recall Number
D-0357-2021
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
2,627 bottles
Firm Location
South San Francisco, CA, United States

Reason for Recall

Defective Container: complaints received regarding some incorrect press-in-bottle-adapters (PIBA), the incorrect PIBAs have a female instead of male fit so they cannot be used in combination with co-packed syringes.

Distribution

Distributed Nationwide in the USA.

Lot / Code Info

Lot #: B1001B05; B1001B08, Exp. Feb-2022

More recalls by Genentech, Inc.

View all recalls by this company →

Other recent Class III Drug recalls